SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

Verrica Pharmaceuticals Q1 EPS $(0.390) Down From $(0.300) YoY

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.390) per share. This is a 30 percent decrease over losses of $(0.300) per share from the same period last year.

Benzinga · 05/07/2020 12:33

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.390) per share. This is a 30 percent decrease over losses of $(0.300) per share from the same period last year.